VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 468 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2015. The put-call ratio across all filers is 0.90 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $42,000 | -69.8% | 51,000 | -31.6% | 0.06% | -73.6% |
| Q2 2017 | $139,000 | +396.4% | 74,600 | +43.5% | 0.24% | +545.9% |
| Q1 2017 | $28,000 | -91.5% | 52,000 | -28.5% | 0.04% | -90.2% |
| Q4 2016 | $328,000 | +146.6% | 72,682 | -10.7% | 0.38% | +258.1% |
| Q3 2016 | $133,000 | -91.7% | 81,400 | -14.5% | 0.10% | -92.4% |
| Q2 2016 | $1,603,000 | -21.8% | 95,200 | -65.0% | 1.38% | -35.9% |
| Q1 2016 | $2,050,000 | +109.6% | 272,100 | +31.3% | 2.15% | +197.4% |
| Q4 2015 | $978,000 | – | 207,200 | – | 0.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |